Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
Injectable cabotegravir makes progress towards human efficacy studies: doubts about injectable rilpivirine

Researchers have determined the dose of an injectable formulation of the integrase inhibitor cabotegravir (formerly GSK744) that will be taken into efficacy trials to see if it

Published
5 hours ago
By
Gus Cairns
Tenofovir gel use associated with lower HSV-2 risk in women

The risk of acquiring herpes simplex virus type 2 (HSV-2) was reduced by 46% (aIRR:0.54, 95%CI:0.30-0.97, p=0.038) among women who regularly used the vaginal gel containing tenofovir, according

Published
5 hours ago
By
Lesley Odendal
PrEP for a new era

It was an exciting morning for pre-exposure prophylaxis (PrEP) using daily oral TDF/FTC (brand-name Truvada).

Published
29 October 2014
From
What's Up HIV (blog)
San Francisco to spend $300K improving access to PrEP

The Board of Supervisors approved spending $300,000 Tuesday to fund so-called navigators to help residents gain access to an HIV-prevention drug, PrEP. The funding will be used to hire people in nonprofits to help residents learn about the drug, which can reduce users' chances of being infected, and to help them use their existing benefits like Medi-Cal to cover the drug expenses.

Published
29 October 2014
From
San Francisco Examiner
Dr. Robert Grant, MD, MPH: The City of Love Could Lead the Way Toward Ending HIV Transmission

As we enter our fourth decade without a cure for HIV, public interest in ending new infections has seemed to wane. Now's not the time to stop talking about AIDS. With important new treatment and prevention tools in our arsenal, San Francisco - known as the City of Love - could be the first U.S. city to end HIV transmission.

Published
29 October 2014
From
Huffington Post
Second European PrEP study closes placebo arm early due to high effectiveness

In an extraordinary development, a second European scientific trial of pre-exposure prophylaxis (PrEP) has had its randomised phase closed early due to high effectiveness, just two weeks after the

Published
29 October 2014
By
Gus Cairns
PrEP Pops Up On Cruising Sites

We are now seeing the emergence of profiles where guys self-identify as PrEP users on cruising sites and apps like Grindr and Squirt. Is this a signal that PrEP is now a part of gay men’s sex lives? I decided to check out one of these sites to see what was happening.

Published
22 October 2014
From
Positive Lite
High effectiveness seen in English PrEP trial

The Steering Committee* of the PROUD trial of pre-exposure prophylaxis (PrEP) in gay men in England announced today that participants currently on the deferred arm of the

Published
16 October 2014
By
Gus Cairns
The Welcome Side Effect of PrEP

A spike in relationships that bridge the so-called viral divide may be an unintended side effect of the use of PrEP for HIV prevention.

Published
14 October 2014
From
The Advocate
The Pill Truvada Can Prevent HIV/AIDS, and for Some, That's a Problem

Researchers estimate that PrEP is over 90 percent effective if taken as prescribed. The PrEP program also calls for screenings for HIV and sexually transmitted infections at three-month intervals. This addresses a challenge doctors have struggled with for years: keeping at-risk people in contact with medical care for regular testing and rapid treatment. But despite its promise, PrEP has generated significant controversy in the LGBT and public health communities.

Published
08 October 2014
From
Newsweek
← First12345...43Next →

Filter by country